Zai Lab (ZLAB) Depreciation and Depletion (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Depreciation and Depletion of $2.3 million for Q1 2026, up 15.0% year-on-year from $2.0 million in Q1 2025, and down 4.17% on a QoQ basis from $2.4 million in Q4 2025.
Zai Lab (ZLAB) Depreciation and Depletion (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Depreciation and Depletion for 9 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- Quarterly Depreciation and Depletion rose 15.0% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 13.25% YoY) and the FY2025 annual result came in at $9.1 million, up 5.81% from the prior year.
- Depreciation and Depletion declined to $2.3 million in Q1 2026 per ZLAB's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for ZLAB reached as high as $2.5 million in Q1 2023 and fell as low as $1.7 million in Q2 2022.
- A 5-year average of $2.1 million and a median of $2.1 million in 2022 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion soared 41.79% — and 2023, when it decreased 14.29%.
- Year by year, Depreciation and Depletion stood at $2.0 million in 2022, then gained by 15.0% to $2.3 million in 2023, then dropped by 13.04% to $2.0 million in 2024, then climbed by 20.0% to $2.4 million in 2025, then slipped by 4.17% to $2.3 million in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $2.3 million, $2.4 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |